Core Framework & Diagram B Cells: The Antibody Factory

Not necessarily — it depends on the type and function. High levels of protective antibodies against specific pathogens (such as vaccine-induced neutralizing antibodies) do represent good protection against that pathogen. But high levels of autoantibodies (attacking the body's own tissue) are a signal of autoimmune disease — immune dysregulation, not immune strength. Antibody levels only have meaning in the context of which specific pathogen and which specific antibody type.

IVIG is passive immunization — directly providing a mixed pool of antibodies from large numbers of donor blood samples, giving the recipient immediate antibody protection against many pathogens. Unlike active immunization (vaccines, where your own immune system produces antibodies), passive immunization takes effect immediately but is short-lived (injected antibodies degrade within weeks to months). Main uses: emergency post-exposure prevention (such as rabies), replacement therapy for immunodeficient patients, and treatment of certain autoimmune diseases.

Allergic reactions (particularly IgE-mediated) occur when B cells produce the wrong type of antibody — IgE antibodies targeting inherently harmless substances (pollen, peanut proteins, dust mites). These IgE antibodies coat the surface of mast cells and basophils. When the same allergen re-enters the body, it binds these IgE antibodies, triggering mast cell degranulation and releasing large amounts of histamine and other inflammatory mediators — producing allergic symptoms. This is essentially the adaptive immune system 'identifying the wrong target.'

Monoclonal antibodies (mAbs) are laboratory-produced antibodies targeting a single specific molecule. They can target cancer cell-specific surface proteins (such as trastuzumab targeting HER2 for breast cancer), immune checkpoint molecules (pembrolizumab targeting PD-1, restoring T cell attacks on cancer), inflammatory cytokines (tocilizumab targeting IL-6, suppressing rheumatoid arthritis or cytokine storms), and viral proteins (COVID-19 neutralizing antibody therapies). Monoclonal antibodies are the most precision-engineered category of biologic drugs currently available.